1-9 of 9
Jerry Wallweber
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1196: Combination of neuregulin with EGFR activation signatures predict activity of the anti-ErbB3 antibody KTN3379 in SCCHN

Gwenda F. Ligon, Jay S. Lillquist, Scott B. Seibel, Jerry Wallweber, Veronique Neumeister, David L. Rimm, Theresa M. LaVallee, Diego Alvarado
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 1196.
https://doi.org/10.1158/1538-7445.AM2016-1196
Published: 15 July 2016
View article titled, Abstract 1196: Combination of neuregulin with EGFR activation signatures predict activity of the anti-ErbB3 antibody KTN3379 in SCCHN
Journal Articles

Abstract 1558: Association of ErbB/HER biomarkers with antitumor activity of the anti-ErbB3/HER3 monoclonal antibody KTN3379 in SCCHN

Diego Alvarado, Jerry Wallweber, Scott Seibel, Ahmed Chenna, Roy Ravanera, Weidong Huang, David Stathas, Paul Theobald, Theresa M. LaVallee
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1558.
https://doi.org/10.1158/1538-7445.AM2015-1558
Published: 01 August 2015
View article titled, Abstract 1558: Association of ErbB/HER biomarkers with antitumor activity of the anti-ErbB3/HER3 monoclonal antibody KTN3379 in SCCHN
Journal Articles

Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers

Joan T. Garrett, Cammie R. Sutton, Richard Kurupi, Carl Uli Bialucha, Seth A. Ettenberg, Scott D. Collins, Qing Sheng, Jerry Wallweber, Lisa DeFazio-Eli, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2013) 73 (19): 6013–6023.
https://doi.org/10.1158/0008-5472.CAN-13-1191
Published: 01 October 2013
View article titled, Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers
Open the PDF for Combination of Antibody That Inhibits Ligand-Independent HER3 Dimerization and a p110α Inhibitor Potently Blocks PI3K Signaling and Growth of HER2+ Breast Cancers in another window
Includes: Supplementary data
Journal Articles

Abstract 3029: Profiling HER3/ErbB3 activation in formalin-fixed, paraffin-embedded (FFPE) breast tumor samples that express high and low HER2/ErbB2 levels using proximity-based immunoassays.

Jerry Wallweber, Ahmed Chenna, Roy Ravanera, Weidong Huang, David Stathas, Gayle Marshall, Chris Womack, Alison Pritchard, Ken Thress, Carl Barrett, Christos Petropoulos, Lisa DeFazio Eli, John Winslow
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3029.
https://doi.org/10.1158/1538-7445.AM2013-3029
Published: 15 April 2013
View article titled, Abstract 3029: Profiling HER3/ErbB3 activation in formalin-fixed, paraffin-embedded (FFPE) breast tumor samples that express high and low HER2/ErbB2 levels using proximity-based immunoassays.
Journal Articles

Abstract 5461: A HER3 antibody that blocks ligand-independent HER2-HER3 dimerization sensitizes to HER2 and PI3K inhibitors .

Joan T. Garrett, Cammie R. Sutton, Carl Uli Bialucha, Seth A. Ettenberg, Jerry Wallweber, Lisa DeFazio-Eli, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5461.
https://doi.org/10.1158/1538-7445.AM2013-5461
Published: 15 April 2013
View article titled, Abstract 5461: A HER3 antibody that blocks ligand-independent HER2-HER3 dimerization sensitizes to HER2 and PI3K inhibitors .
Journal Articles

Abstract LB-323: Subclassification of squamous cell carcinomas of the head and neck based on HER/ErbB and c-MET receptor protein expression and activation profiles

Jerry Wallweber, Youssouf Badal, Brian Twomey, Tam Dang, Jolly Bose, Trang Dao-Pick, Jianhuan Zhang, Dave Stathas, Rajiv Dua, Tom Sherwood, Weidong Huang, Gordon Parry, Kelly Oliner, John W. Winslow
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): LB-323.
https://doi.org/10.1158/1538-7445.AM2011-LB-323
Published: 15 April 2011
View article titled, Abstract LB-323: Subclassification of squamous cell carcinomas of the head and neck based on HER/ErbB and c-MET receptor protein expression and activation profiles
Journal Articles

Abstract #5244: Quantitative, sensitive, and reproducible measurement of epidermal growth factor receptor/HER1 homodimerization and total expression in formalin-fixed, paraffin-embedded tumors using a novel proximity-based assay

Yining Shi, Jerry Wallweber, Jolly Bose, Tam Dang, Agnes Paquet, Colombe Chappey, Gordon Parry, Laurie Goodman, John Winslow
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5244.
Published: 01 May 2009
View article titled, Abstract #5244: Quantitative, sensitive, and reproducible measurement of epidermal growth factor receptor/HER1 homodimerization and total expression in formalin-fixed, paraffin-embedded tumors using a novel proximity-based assay
Journal Articles

Abstract #5247: Quantitative measurements of phosphorylated HER1, HER2, and HER1-HER2 heterodimers in formalin-fixed, paraffin-embedded (FFPE) breast and head/neck tumors using proximity-based immunoassays

Lisa DeFazio Eli, Trang Dao-Pick, Kristi Frankson, Jerry Wallweber, Tam Dang, Gordon Parry, Laurie Goodman, John Winslow
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 5247.
Published: 01 May 2009
View article titled, Abstract #5247: Quantitative measurements of phosphorylated HER1, HER2, and HER1-HER2 heterodimers in formalin-fixed, paraffin-embedded (FFPE) breast and head/neck tumors using proximity-based immunoassays
Journal Articles

Multiplexed assay for assessing ErbB/HER receptor pathways in formalin-fixed and paraffin-embedded cancer cell lines

Yining Shi, Rajiv Dua, Ali Mukherjee, Liching Cao, Yuping Tan, Laura Jarvis, Herjit Pannu, Thuy-Ngoc Nguyen, Ahmed Chenna, Jerry Wallweber, Sharat Singh
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 1354.
Published: 01 May 2005
View article titled, Multiplexed assay for assessing ErbB/HER receptor pathways in formalin-fixed and paraffin-embedded cancer cell lines